Melting gel techniques in single nucleotide polymorphism and mutation detection: From theory to automationBJØRHEIM, Jens; GAUDERNACK, Gustav; EKSTRØM, Per Olaf et al.Journal of separation science. 2002, Vol 25, Num 10-11, pp 637-647, issn 1615-9306Article

mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)SAEBØE-LARSSEN, Stein; FOSSBERG, Ellen; GAUDERNACK, Gustav et al.Journal of immunological methods. 2002, Vol 259, Num 1-2, pp 191-203, issn 0022-1759Article

Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresisBJØRHEIM, Jens; ABRAHAMSEN, Torveig Weum; KRISTENSEN, Annette Torgunrud et al.Mutation research. Fundamental and molecular mechanisms of mutagenesis. 2003, Vol 526, Num 1-2, pp 75-83, issn 1386-1964, 9 p.Article

Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapyFOSSA, Alexander; LILLEBY, Wolfgang; FOSSA, Sophie D et al.International journal of cancer. 2002, Vol 99, Num 1, pp 100-105, issn 0020-7136Article

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccinationKYTE, Jon Amund; TRACHSEL, Sissel; RISBERG, Bente et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 10, pp 1609-1626, issn 0340-7004, 18 p.Article

Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2KERSTEN, Christian; DELABIE, Jan; GAUDERNACK, Gustav et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 12, pp 1119-1126, issn 0340-7004, 8 p.Article

A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8⁺ T cellsSAETERDAL, Ingvil; GJERTSEN, Marianne K; STRATEN, Perthor et al.Cancer immunology and immunotherapy. 2001, Vol 50, Num 9, pp 469-476, issn 0340-7004Article

Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethanePAULSEN, Jan Erik; BJØRHEIM, Jens; RØE, Janne et al.Anticancer research. 2002, Vol 22, Num 1A, pp 171-175, issn 0250-7005Article

Telomerase peptide vaccination : a phase I/II study in patients with non-small cell lung cancerBRUNSVIG, Paal F; AAMDAL, Steinar; GAUDERNACK, Gustav et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 12, pp 1553-1564, issn 0340-7004, 12 p.Article

hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopesINDERBERG SUSO, Else M; DUELAND, Svein; RASMUSSEN, Anne-Marie et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 6, pp 809-818, issn 0340-7004, 10 p.Article

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinomaGJERTSEN, Marianne K; BUANES, Trond; SAETERDAL, Ingvil et al.International journal of cancer. 2001, Vol 92, Num 3, pp 441-450, issn 0020-7136Article

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II TrialBRUNSVIG, Paal Fr; AMUND KYTE, Jon; KERSTEN, Christian et al.Clinical cancer research (Print). 2011, Vol 17, Num 21, pp 6847-6857, issn 1078-0432, 11 p.Article

Vaccination of patients with cutaneous melanoma with telomerase-specific peptidesHUNGER, Robert E; MARKOWSKI, Carrie J; TRACHSEL, Sissel et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 11, pp 1553-1564, issn 0340-7004, 12 p.Article

Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapyRASMUSSEN, Anne-Marie; BORELLI, Gabriel; HOEL, Hanna Julie et al.Journal of immunological methods. 2010, Vol 355, Num 1-2, pp 52-60, issn 0022-1759, 9 p.Article